H. Lakkis

250. Efficacy of adjunctive lumateperone 42 mg treatment across patient-reported depression symptoms in major depressive disorder

Abstract Background Patient-reported outcomes are increasingly used as endpoints in clinical trials, as they offer a unique perspective about symptoms and ensure comprehensive treatment assessment. Because patients with major depressive disorder (MDD) often experience persistent depression symptoms, a treatment for MDD...